Arena Pharmaceuticals, Inc. (ARNA) reported a second-quarter net loss allocable to common stockholders of $22.1 million or $0.12 per share, narrower than $22.9 million or $0.16 per share in the year-ago quarter.
Total revenue for the second quarter rose to $21.98 million from $3.26 million in the comparable quarter last year.
On average, analysts polled by Thomson Reuters expected the company report a loss of $0.07 per share on revenue of $10.04 million for the second quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.